BioCryst Pharmaceuticals (BCRX) rose amid takeover speculation.
There's some talk that BioCryst (BCRX) may be a takeover target, according to traders, who cited a Betaville "uncooked" alert that was circulating on Monday.
Some people following the matter have heard that the party interested in BioCryst (BCRX) may be a US-based biopharma with a market cap of more than $15 billion, according to the report.
BioCryst (BCRX) has a market cap of $2 billion.
https://www.msn.com/en-us/money/companies/biocryst-gains-amid-takeover-speculation/ar-AA1YKxRF
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.